Zürcher Kantonalbank Discloses Position in Avadel Pharmaceuticals

Zürcher Kantonalbank has submitted Form 8.3, detailing its position in Avadel Pharmaceuticals plc. This disclosure is in accordance with Rule 8.3 of the Irish Takeover Panel Act, 1997, Takeover Rules, 2022, applicable to entities with interests in securities representing 1% or more.

The bank, along with its subsidiaries, reported ownership of 992,397 ordinary shares, comprising 1.02% of Avadel's relevant securities. The disclosure, dated 31st December 2025, confirms no involvement with other parties regarding this offer, with no reported engagements in cash-settled or stock-settled derivative transactions beyond listed title transfer collateral deals.

No indemnity or inducement arrangements exist, underscoring a straightforward position in Avadel securities without supplementary agreements influencing transactions or voting rights.